Device Trial Radar · NCT07907068
Registry of Central Sleep Apnea Patients Undergoing remedē System Implant
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Mar 2027
Primary completion
May 2033
Study completion May 2037
Sponsor
- Lead sponsor
- Zoll Medical CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 30, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to collect information on the safety and performance of the remedē System in patients with central sleep apnea who are undergoing the remedē System implant procedure. The main question\[s\] it aims to answer \[is/are\]: What is the incidence of serious adverse events related to the remedē System implant procedure, device, or delivered therapy through 12 months post implant. Participants will complete 2 home sleep apnea tests and be asked about adverse events. All other data collected will be from standard of care visits.
Conditions
- Central Sleep Apnea (Diagnosis)
- Central Sleep Apnea Syndrome
- Central Sleep Apnea
- Sleep Apnea, Central
Interventions
Phrenic nerve stimulationDevice
remede System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of serious adverse events (SAEs) related to the remedē System implant procedure, device, or delivered therapy through 12 months post implantTime frame: From implant to 12 months post implant
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.